ExpreS2ion Biotech Holding AB (publ)
Save
153.96M
Market cap
–
Current P/E
25.38x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark. The company develops capsid virus-like particle COVID-19 vaccine, which is in Phase II clinical trial. It also develops influenza and breast cancer vaccine, which is in Phase II clinical trial, as well as develops malaria vaccine.
Similar securities
Based on sector and market capitalization
Report issue